Pharmacyclics, Inc. (PCYC) Posts Q4 Loss of 22c/Share
Tweet
Share
E-mailGet Alerts PCYC Hot Sheet
Price: $261.25 --0%
Financial Fact:
Total revenues: 205.77M
Today's EPS Names:
EGRX, MOVE, MDRX, More
Financial Fact:
Total revenues: 205.77M
Today's EPS Names:
EGRX, MOVE, MDRX, More
Join SI Premium – FREE
Pharmacyclics, Inc. (NASDAQ: PCYC) reported Q4 EPS of ($0.22), $0.05 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $2.1 million versus the consensus estimate of $3.49 million.
For earnings history and earnings-related data on Pharmacyclics, Inc. (PCYC) click here.
For earnings history and earnings-related data on Pharmacyclics, Inc. (PCYC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Needham Reiterates Buy Rating on Digimarc (DMRC)
- Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
